101 集

We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.

The Fellow on Call: The Heme/Onc Podcast Rouleaux University Medical Center

    • 健康與體能

We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.

    Episode 101: Colorectal Cancer Series, Pt. 3 - Stage II Colon Cancer and ctDNA

    Episode 101: Colorectal Cancer Series, Pt. 3 - Stage II Colon Cancer and ctDNA

    In this week’s episode, we discuss the management of stage II colon adenocarcinoma, which is defined by a lack of nodal involvement and invasion through the muscularis layer of the colon. If you have not done so already, be sure to check out episode 099 (overview of colorectal cancer) and episode 100 for stage III colon cancer, as we will building on concepts discussed already.

    Content:
    - Is there a role for adjuvant chemotherapy in stage II colon cancer patients?
    - What is the impact on MSI/MMR testing in stage II colon cancer patients?
    - Is there a role for evaluating circulating tumor DNA (ctDNA) in colon cancer patients?
    - Is there a role for immunotherapy in the adjuvant setting?

    ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

    Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

    Twitter: @TheFellowOnCall
    Instagram: @TheFellowOnCall
    Listen in on: Apple Podcast, Spotify, and Google Podcast

    Episode 100: Colorectal Cancer Series, Pt. 2 - Adjuvant Therapy in Stage III Colon Cancer

    Episode 100: Colorectal Cancer Series, Pt. 2 - Adjuvant Therapy in Stage III Colon Cancer

    This week, we kick off our discussion of adjuvant systemic treatment in colon cancer, beginning with Stage III colon cancer. We will review the evidence basis for adjuvant therapy as well as the two main chemotherapy regimens including duration and side effects.

    Content:
    - Why do we need adjuvant therapy in stage III colon cancer?
    - What is FOLFOX? What is CAPOX? When do we use what?
    - What is the optimal duration of therapy?
    - What are the characteristics deemed high risk?
    - Can we discontinue oxaliplatin early?
    - What is the role of oxaliplatin in older patients?

    ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

    Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

    Twitter: @TheFellowOnCall
    Instagram: @TheFellowOnCall
    Listen in on: Apple Podcast, Spotify, and Google Podcast

    Episode 099: Colorectal Cancer Series, Pt. 1 - Intro to Colorectal Cancer

    Episode 099: Colorectal Cancer Series, Pt. 1 - Intro to Colorectal Cancer

    Colorectal cancer is one of the most common cancers diagnosed each year worldwide. This highly anticipated series will take an in-depth look at this disease. In this first episode, we discuss the basics, including staging, tumor markers, and microsatellite instability testing, before tackling the management of colorectal cancer in upcoming episodes.

    Content:
    - What is the incidence of colorectal cancer (CRC) in the US?
    - How are CRC patients staged?
    - What is the role of CEA?
    - What are microsatellites and mismatch repair proteins, and how do they come into play for treatment purposes?
    - Who needs germline testing?
    - What is the TNM staging for CRC?
    - What are some high risk factors we need to pay attention to on the pathology report?

    ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

    Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

    Twitter: @TheFellowOnCall
    Instagram: @TheFellowOnCall
    Listen in on: Apple Podcast, Spotify, and Google Podcast

    Episode 098: Understanding MRD Testing in CLL

    Episode 098: Understanding MRD Testing in CLL

    With multiple options for frontline therapy in CLL, MRD has the potential to emerge as a factor that could be considered in our decision-making algorithm for sequencing treatment options. In this week’s episode, we dive into a deeper understanding of the role of MRD testing in CLL.

    Content:
    - What is the role of MRD testing in CLL?
    - What are the techniques we use to evaluate for MRD?
    - What is the prognostic role of MRD testing?
    - Is there data to change treatment based on MRD testing?

    ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

    Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

    Twitter: @TheFellowOnCall
    Instagram: @TheFellowOnCall
    Listen in on: Apple Podcast, Spotify, and Google Podcast

    Episode 097: Treatment of Relapsed/Refractory CLL

    Episode 097: Treatment of Relapsed/Refractory CLL

    This week, we continue our discussion of treatment of CLL, this time focusing on the relapsed/refractory CLL. If you have not done so, we recommend checking out our prior episodes since we will be building on these conversations!

    Content:
    -If you suspect your patient has relapsed, what do you do?
    -What is the approach to treatment in the relapsed/refractory setting?
    - What is Richter's transformation?

    ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

    Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

    Twitter: @TheFellowOnCall
    Instagram: @TheFellowOnCall
    Listen in on: Apple Podcast, Spotify, and Google Podcast

    Episode 096: Treatment of CLL

    Episode 096: Treatment of CLL

    We continue on our journey through chronic lymphocytic lymphoma (CLL), this time focusing our attention to the treatment of CLL. 

    Content:
    - What are the indications for treatment?
    - Can I wait to treat and not impact OS?
    - What is our current approach to treatment ?
    - Fixed duration vs. indefinite treatment options?

    ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

    Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

    Twitter: @TheFellowOnCall
    Instagram: @TheFellowOnCall
    Listen in on: Apple Podcast, Spotify, and Google Podcast

關於健康與體能的熱門 Podcast

健人港人話 Steven Talks
Steven Yu
Huberman Lab
Scicomm Media
The Psychology of your 20s
iHeartPodcasts
自习室 STUDY ROOM
不好惹的娃娃脸
On Purpose with Jay Shetty
iHeartPodcasts
ZOE Science & Nutrition
ZOE

你可能也會喜歡

Two Onc Docs
Sam and Karine
Plenary Session
Vinay Prasad, MD MPH
Core IM | Internal Medicine Podcast
Core IM Team
The Clinical Problem Solvers
The Clinical Problem Solvers
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
JAMA Clinical Reviews
JAMA Network